Recent research focusing on Tirzepatide at a dosage of 30mg is shedding new light on its potential applications. Initial findings suggest that this higher dosage may amplify the drug's ability to control blood levels, potentially offering greater outcomes for individuals with diabetes. Further study is underway to fully evaluate the long-term safet